Global (United States, European Union and China) Over The Counter (OTC) Drugs

Over The Counter (OTC) Drugs Comprehensive Study by Type (Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others), Distribution Chanel (Pharmacies, Grocery Stores, Vitamin and Health Food Stores, Online Pharmacy, Others), Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Others) Players and Region - Global Market Outlook to 2024

Over The Counter (OTC) Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Scope of the Study

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional that are safe for use by the general public. OTC drugs are regulated according to their active pharmaceutical ingredient rather than final products. These medications are used to treat a variety of symptoms due to illness including pain, coughs and colds, diarrhea, heartburn, constipation, acne and others. In many countries, over-the-counter drugs are available in establishments without pharmacy such as supermarkets, general stores and gas stations.

The market study is being classified by Type (Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids and Others) and major geographies with country level break-up.

Pfizer Inc. (United States), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Merck & Co., Inc. (United States), Sanofi S.A (France), Johnson & Johnson (United States), Gilead Sciences, Inc. (United States), GlaxoSmithKline plc. (United Kingdom), Bayer Healthcare AG (Germany) and AstraZeneca plc. (United Kingdom) are some of the key players profiled in the study.

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Over The Counter (OTC) Drugs market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Over The Counter (OTC) Drugs market by Type, Application and Region.

On the basis of geography, the market of Over The Counter (OTC) Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Awareness Related To General Health Concerns
  • Growing Number of Regulatory Approvals
  • Increase in Healthcare Expenditure

Market Trend
  • Growing Trend of Purchasing OTC Drugs for Seasonal Diseases

Restraints
  • Side Effects of OTC Drugs

Opportunities
  • Growing Geriatric Population Worldwide
  • Increasing Number of Pharmacy Stores
  • Growth in the Pharmaceutical Industry in Developing Countries

Challenges
  • Stringent Government Rules and Regulations in Some Regions



“In the United States, the manufacture and sale of OTC substances are regulated by the Food and Drug Administration. The FDA requires that all "new drugs" obtain a New Drug Application (NDA) before entering interstate commerce, but the act exempts any drugs generally recognized as safe and effective.”

Key Target Audience
Over The Counter (OTC) Drugs Manufacturers, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Mineral, and Supplements (VMS)
  • Weight Loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others
By Distribution Chanel
  • Pharmacies
  • Grocery Stores
  • Vitamin and Health Food Stores
  • Online Pharmacy
  • Others

By Form
  • Tablets
  • Hard Capsules
  • Powders
  • Ointments
  • Soft Capsules
  • Liquids
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Awareness Related To General Health Concerns
      • 3.2.2. Growing Number of Regulatory Approvals
      • 3.2.3. Increase in Healthcare Expenditure
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations in Some Regions
    • 3.4. Market Trends
      • 3.4.1. Growing Trend of Purchasing OTC Drugs for Seasonal Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Over The Counter (OTC) Drugs, by Type, Distribution Chanel, Form and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Over The Counter (OTC) Drugs (Value)
      • 5.2.1. Global Over The Counter (OTC) Drugs by: Type (Value)
        • 5.2.1.1. Analgesics
        • 5.2.1.2. Dermatology Products
        • 5.2.1.3. Gastrointestinal Products
        • 5.2.1.4. Vitamins, Mineral, and Supplements (VMS)
        • 5.2.1.5. Weight Loss/Dietary Products
        • 5.2.1.6. Ophthalmic Products
        • 5.2.1.7. Sleeping Aids
        • 5.2.1.8. Others
      • 5.2.2. Global Over The Counter (OTC) Drugs by: Distribution Chanel (Value)
        • 5.2.2.1. Pharmacies
        • 5.2.2.2. Grocery Stores
        • 5.2.2.3. Vitamin and Health Food Stores
        • 5.2.2.4. Online Pharmacy
        • 5.2.2.5. Others
      • 5.2.3. Global Over The Counter (OTC) Drugs by: Form (Value)
        • 5.2.3.1. Tablets
        • 5.2.3.2. Hard Capsules
        • 5.2.3.3. Powders
        • 5.2.3.4. Ointments
        • 5.2.3.5. Soft Capsules
        • 5.2.3.6. Liquids
        • 5.2.3.7. Others
      • 5.2.4. Global Over The Counter (OTC) Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Over The Counter (OTC) Drugs (Volume)
      • 5.3.1. Global Over The Counter (OTC) Drugs by: Type (Volume)
        • 5.3.1.1. Analgesics
        • 5.3.1.2. Dermatology Products
        • 5.3.1.3. Gastrointestinal Products
        • 5.3.1.4. Vitamins, Mineral, and Supplements (VMS)
        • 5.3.1.5. Weight Loss/Dietary Products
        • 5.3.1.6. Ophthalmic Products
        • 5.3.1.7. Sleeping Aids
        • 5.3.1.8. Others
      • 5.3.2. Global Over The Counter (OTC) Drugs by: Distribution Chanel (Volume)
        • 5.3.2.1. Pharmacies
        • 5.3.2.2. Grocery Stores
        • 5.3.2.3. Vitamin and Health Food Stores
        • 5.3.2.4. Online Pharmacy
        • 5.3.2.5. Others
      • 5.3.3. Global Over The Counter (OTC) Drugs by: Form (Volume)
        • 5.3.3.1. Tablets
        • 5.3.3.2. Hard Capsules
        • 5.3.3.3. Powders
        • 5.3.3.4. Ointments
        • 5.3.3.5. Soft Capsules
        • 5.3.3.6. Liquids
        • 5.3.3.7. Others
      • 5.3.4. Global Over The Counter (OTC) Drugs Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Over The Counter (OTC) Drugs (Price)
      • 5.4.1. Global Over The Counter (OTC) Drugs by: Type (Price)
  • 6. Over The Counter (OTC) Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis International AG (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Roche Holding AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sanofi S.A (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Johnson & Johnson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Gilead Sciences, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline plc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bayer Healthcare AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AstraZeneca plc. (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Over The Counter (OTC) Drugs Sale, by Type, Distribution Chanel, Form and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Over The Counter (OTC) Drugs (Value)
      • 7.2.1. Global Over The Counter (OTC) Drugs by: Type (Value)
        • 7.2.1.1. Analgesics
        • 7.2.1.2. Dermatology Products
        • 7.2.1.3. Gastrointestinal Products
        • 7.2.1.4. Vitamins, Mineral, and Supplements (VMS)
        • 7.2.1.5. Weight Loss/Dietary Products
        • 7.2.1.6. Ophthalmic Products
        • 7.2.1.7. Sleeping Aids
        • 7.2.1.8. Others
      • 7.2.2. Global Over The Counter (OTC) Drugs by: Distribution Chanel (Value)
        • 7.2.2.1. Pharmacies
        • 7.2.2.2. Grocery Stores
        • 7.2.2.3. Vitamin and Health Food Stores
        • 7.2.2.4. Online Pharmacy
        • 7.2.2.5. Others
      • 7.2.3. Global Over The Counter (OTC) Drugs by: Form (Value)
        • 7.2.3.1. Tablets
        • 7.2.3.2. Hard Capsules
        • 7.2.3.3. Powders
        • 7.2.3.4. Ointments
        • 7.2.3.5. Soft Capsules
        • 7.2.3.6. Liquids
        • 7.2.3.7. Others
      • 7.2.4. Global Over The Counter (OTC) Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Over The Counter (OTC) Drugs (Volume)
      • 7.3.1. Global Over The Counter (OTC) Drugs by: Type (Volume)
        • 7.3.1.1. Analgesics
        • 7.3.1.2. Dermatology Products
        • 7.3.1.3. Gastrointestinal Products
        • 7.3.1.4. Vitamins, Mineral, and Supplements (VMS)
        • 7.3.1.5. Weight Loss/Dietary Products
        • 7.3.1.6. Ophthalmic Products
        • 7.3.1.7. Sleeping Aids
        • 7.3.1.8. Others
      • 7.3.2. Global Over The Counter (OTC) Drugs by: Distribution Chanel (Volume)
        • 7.3.2.1. Pharmacies
        • 7.3.2.2. Grocery Stores
        • 7.3.2.3. Vitamin and Health Food Stores
        • 7.3.2.4. Online Pharmacy
        • 7.3.2.5. Others
      • 7.3.3. Global Over The Counter (OTC) Drugs by: Form (Volume)
        • 7.3.3.1. Tablets
        • 7.3.3.2. Hard Capsules
        • 7.3.3.3. Powders
        • 7.3.3.4. Ointments
        • 7.3.3.5. Soft Capsules
        • 7.3.3.6. Liquids
        • 7.3.3.7. Others
      • 7.3.4. Global Over The Counter (OTC) Drugs Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Over The Counter (OTC) Drugs (Price)
      • 7.4.1. Global Over The Counter (OTC) Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Over The Counter (OTC) Drugs: by Type(USD Million)
  • Table 2. Over The Counter (OTC) Drugs Analgesics , by Region USD Million (2013-2018)
  • Table 3. Over The Counter (OTC) Drugs Dermatology Products , by Region USD Million (2013-2018)
  • Table 4. Over The Counter (OTC) Drugs Gastrointestinal Products , by Region USD Million (2013-2018)
  • Table 5. Over The Counter (OTC) Drugs Vitamins, Mineral, and Supplements (VMS) , by Region USD Million (2013-2018)
  • Table 6. Over The Counter (OTC) Drugs Weight Loss/Dietary Products , by Region USD Million (2013-2018)
  • Table 7. Over The Counter (OTC) Drugs Ophthalmic Products , by Region USD Million (2013-2018)
  • Table 8. Over The Counter (OTC) Drugs Sleeping Aids , by Region USD Million (2013-2018)
  • Table 9. Over The Counter (OTC) Drugs Others , by Region USD Million (2013-2018)
  • Table 10. Over The Counter (OTC) Drugs: by Distribution Chanel(USD Million)
  • Table 11. Over The Counter (OTC) Drugs Pharmacies , by Region USD Million (2013-2018)
  • Table 12. Over The Counter (OTC) Drugs Grocery Stores , by Region USD Million (2013-2018)
  • Table 13. Over The Counter (OTC) Drugs Vitamin and Health Food Stores , by Region USD Million (2013-2018)
  • Table 14. Over The Counter (OTC) Drugs Online Pharmacy , by Region USD Million (2013-2018)
  • Table 15. Over The Counter (OTC) Drugs Others , by Region USD Million (2013-2018)
  • Table 16. Over The Counter (OTC) Drugs: by Form(USD Million)
  • Table 17. Over The Counter (OTC) Drugs Tablets , by Region USD Million (2013-2018)
  • Table 18. Over The Counter (OTC) Drugs Hard Capsules , by Region USD Million (2013-2018)
  • Table 19. Over The Counter (OTC) Drugs Powders , by Region USD Million (2013-2018)
  • Table 20. Over The Counter (OTC) Drugs Ointments , by Region USD Million (2013-2018)
  • Table 21. Over The Counter (OTC) Drugs Soft Capsules , by Region USD Million (2013-2018)
  • Table 22. Over The Counter (OTC) Drugs Liquids , by Region USD Million (2013-2018)
  • Table 23. Over The Counter (OTC) Drugs Others , by Region USD Million (2013-2018)
  • Table 24. South America Over The Counter (OTC) Drugs, by Country USD Million (2013-2018)
  • Table 25. South America Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 26. South America Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 27. South America Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 28. Brazil Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 29. Brazil Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 30. Brazil Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 31. Argentina Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 32. Argentina Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 33. Argentina Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 34. Rest of South America Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 35. Rest of South America Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 36. Rest of South America Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 37. Asia Pacific Over The Counter (OTC) Drugs, by Country USD Million (2013-2018)
  • Table 38. Asia Pacific Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 39. Asia Pacific Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 40. Asia Pacific Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 41. China Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 42. China Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 43. China Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 44. Japan Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 45. Japan Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 46. Japan Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 47. India Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 48. India Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 49. India Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 50. South Korea Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 51. South Korea Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 52. South Korea Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 53. Taiwan Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 54. Taiwan Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 55. Taiwan Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 56. Australia Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 57. Australia Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 58. Australia Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 59. Rest of Asia-Pacific Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 60. Rest of Asia-Pacific Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 61. Rest of Asia-Pacific Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 62. Europe Over The Counter (OTC) Drugs, by Country USD Million (2013-2018)
  • Table 63. Europe Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 64. Europe Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 65. Europe Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 66. Germany Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 67. Germany Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 68. Germany Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 69. France Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 70. France Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 71. France Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 72. Italy Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 73. Italy Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 74. Italy Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 75. United Kingdom Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 76. United Kingdom Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 77. United Kingdom Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 78. Netherlands Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 79. Netherlands Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 80. Netherlands Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 81. Rest of Europe Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 82. Rest of Europe Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 83. Rest of Europe Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 84. MEA Over The Counter (OTC) Drugs, by Country USD Million (2013-2018)
  • Table 85. MEA Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 86. MEA Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 87. MEA Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 88. Middle East Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 89. Middle East Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 90. Middle East Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 91. Africa Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 92. Africa Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 93. Africa Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 94. North America Over The Counter (OTC) Drugs, by Country USD Million (2013-2018)
  • Table 95. North America Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 96. North America Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 97. North America Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 98. United States Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 99. United States Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 100. United States Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 101. Canada Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 102. Canada Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 103. Canada Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 104. Mexico Over The Counter (OTC) Drugs, by Type USD Million (2013-2018)
  • Table 105. Mexico Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2013-2018)
  • Table 106. Mexico Over The Counter (OTC) Drugs, by Form USD Million (2013-2018)
  • Table 107. Over The Counter (OTC) Drugs Sales: by Type(K Units)
  • Table 108. Over The Counter (OTC) Drugs Sales Analgesics , by Region K Units (2013-2018)
  • Table 109. Over The Counter (OTC) Drugs Sales Dermatology Products , by Region K Units (2013-2018)
  • Table 110. Over The Counter (OTC) Drugs Sales Gastrointestinal Products , by Region K Units (2013-2018)
  • Table 111. Over The Counter (OTC) Drugs Sales Vitamins, Mineral, and Supplements (VMS) , by Region K Units (2013-2018)
  • Table 112. Over The Counter (OTC) Drugs Sales Weight Loss/Dietary Products , by Region K Units (2013-2018)
  • Table 113. Over The Counter (OTC) Drugs Sales Ophthalmic Products , by Region K Units (2013-2018)
  • Table 114. Over The Counter (OTC) Drugs Sales Sleeping Aids , by Region K Units (2013-2018)
  • Table 115. Over The Counter (OTC) Drugs Sales Others , by Region K Units (2013-2018)
  • Table 116. Over The Counter (OTC) Drugs Sales: by Distribution Chanel(K Units)
  • Table 117. Over The Counter (OTC) Drugs Sales Pharmacies , by Region K Units (2013-2018)
  • Table 118. Over The Counter (OTC) Drugs Sales Grocery Stores , by Region K Units (2013-2018)
  • Table 119. Over The Counter (OTC) Drugs Sales Vitamin and Health Food Stores , by Region K Units (2013-2018)
  • Table 120. Over The Counter (OTC) Drugs Sales Online Pharmacy , by Region K Units (2013-2018)
  • Table 121. Over The Counter (OTC) Drugs Sales Others , by Region K Units (2013-2018)
  • Table 122. Over The Counter (OTC) Drugs Sales: by Form(K Units)
  • Table 123. Over The Counter (OTC) Drugs Sales Tablets , by Region K Units (2013-2018)
  • Table 124. Over The Counter (OTC) Drugs Sales Hard Capsules , by Region K Units (2013-2018)
  • Table 125. Over The Counter (OTC) Drugs Sales Powders , by Region K Units (2013-2018)
  • Table 126. Over The Counter (OTC) Drugs Sales Ointments , by Region K Units (2013-2018)
  • Table 127. Over The Counter (OTC) Drugs Sales Soft Capsules , by Region K Units (2013-2018)
  • Table 128. Over The Counter (OTC) Drugs Sales Liquids , by Region K Units (2013-2018)
  • Table 129. Over The Counter (OTC) Drugs Sales Others , by Region K Units (2013-2018)
  • Table 130. South America Over The Counter (OTC) Drugs Sales, by Country K Units (2013-2018)
  • Table 131. South America Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 132. South America Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 133. South America Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 134. Brazil Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 135. Brazil Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 136. Brazil Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 137. Argentina Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 138. Argentina Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 139. Argentina Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 140. Rest of South America Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 141. Rest of South America Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 142. Rest of South America Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 143. Asia Pacific Over The Counter (OTC) Drugs Sales, by Country K Units (2013-2018)
  • Table 144. Asia Pacific Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 145. Asia Pacific Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 146. Asia Pacific Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 147. China Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 148. China Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 149. China Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 150. Japan Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 151. Japan Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 152. Japan Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 153. India Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 154. India Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 155. India Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 156. South Korea Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 157. South Korea Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 158. South Korea Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 159. Taiwan Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 160. Taiwan Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 161. Taiwan Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 162. Australia Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 163. Australia Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 164. Australia Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 165. Rest of Asia-Pacific Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 166. Rest of Asia-Pacific Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 167. Rest of Asia-Pacific Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 168. Europe Over The Counter (OTC) Drugs Sales, by Country K Units (2013-2018)
  • Table 169. Europe Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 170. Europe Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 171. Europe Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 172. Germany Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 173. Germany Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 174. Germany Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 175. France Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 176. France Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 177. France Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 178. Italy Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 179. Italy Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 180. Italy Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 181. United Kingdom Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 182. United Kingdom Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 183. United Kingdom Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 184. Netherlands Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 185. Netherlands Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 186. Netherlands Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 187. Rest of Europe Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 188. Rest of Europe Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 189. Rest of Europe Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 190. MEA Over The Counter (OTC) Drugs Sales, by Country K Units (2013-2018)
  • Table 191. MEA Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 192. MEA Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 193. MEA Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 194. Middle East Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 195. Middle East Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 196. Middle East Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 197. Africa Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 198. Africa Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 199. Africa Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 200. North America Over The Counter (OTC) Drugs Sales, by Country K Units (2013-2018)
  • Table 201. North America Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 202. North America Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 203. North America Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 204. United States Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 205. United States Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 206. United States Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 207. Canada Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 208. Canada Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 209. Canada Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 210. Mexico Over The Counter (OTC) Drugs Sales, by Type K Units (2013-2018)
  • Table 211. Mexico Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2013-2018)
  • Table 212. Mexico Over The Counter (OTC) Drugs Sales, by Form K Units (2013-2018)
  • Table 213. Over The Counter (OTC) Drugs: by Type(USD/Units)
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Company Basic Information, Sales Area and Its Competitors
  • Table 219. Company Basic Information, Sales Area and Its Competitors
  • Table 220. Company Basic Information, Sales Area and Its Competitors
  • Table 221. Company Basic Information, Sales Area and Its Competitors
  • Table 222. Company Basic Information, Sales Area and Its Competitors
  • Table 223. Company Basic Information, Sales Area and Its Competitors
  • Table 224. Over The Counter (OTC) Drugs: by Type(USD Million)
  • Table 225. Over The Counter (OTC) Drugs Analgesics , by Region USD Million (2019-2024)
  • Table 226. Over The Counter (OTC) Drugs Dermatology Products , by Region USD Million (2019-2024)
  • Table 227. Over The Counter (OTC) Drugs Gastrointestinal Products , by Region USD Million (2019-2024)
  • Table 228. Over The Counter (OTC) Drugs Vitamins, Mineral, and Supplements (VMS) , by Region USD Million (2019-2024)
  • Table 229. Over The Counter (OTC) Drugs Weight Loss/Dietary Products , by Region USD Million (2019-2024)
  • Table 230. Over The Counter (OTC) Drugs Ophthalmic Products , by Region USD Million (2019-2024)
  • Table 231. Over The Counter (OTC) Drugs Sleeping Aids , by Region USD Million (2019-2024)
  • Table 232. Over The Counter (OTC) Drugs Others , by Region USD Million (2019-2024)
  • Table 233. Over The Counter (OTC) Drugs: by Distribution Chanel(USD Million)
  • Table 234. Over The Counter (OTC) Drugs Pharmacies , by Region USD Million (2019-2024)
  • Table 235. Over The Counter (OTC) Drugs Grocery Stores , by Region USD Million (2019-2024)
  • Table 236. Over The Counter (OTC) Drugs Vitamin and Health Food Stores , by Region USD Million (2019-2024)
  • Table 237. Over The Counter (OTC) Drugs Online Pharmacy , by Region USD Million (2019-2024)
  • Table 238. Over The Counter (OTC) Drugs Others , by Region USD Million (2019-2024)
  • Table 239. Over The Counter (OTC) Drugs: by Form(USD Million)
  • Table 240. Over The Counter (OTC) Drugs Tablets , by Region USD Million (2019-2024)
  • Table 241. Over The Counter (OTC) Drugs Hard Capsules , by Region USD Million (2019-2024)
  • Table 242. Over The Counter (OTC) Drugs Powders , by Region USD Million (2019-2024)
  • Table 243. Over The Counter (OTC) Drugs Ointments , by Region USD Million (2019-2024)
  • Table 244. Over The Counter (OTC) Drugs Soft Capsules , by Region USD Million (2019-2024)
  • Table 245. Over The Counter (OTC) Drugs Liquids , by Region USD Million (2019-2024)
  • Table 246. Over The Counter (OTC) Drugs Others , by Region USD Million (2019-2024)
  • Table 247. South America Over The Counter (OTC) Drugs, by Country USD Million (2019-2024)
  • Table 248. South America Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 249. South America Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 250. South America Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 251. Brazil Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 252. Brazil Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 253. Brazil Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 254. Argentina Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 255. Argentina Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 256. Argentina Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 257. Rest of South America Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 258. Rest of South America Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 259. Rest of South America Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 260. Asia Pacific Over The Counter (OTC) Drugs, by Country USD Million (2019-2024)
  • Table 261. Asia Pacific Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 262. Asia Pacific Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 263. Asia Pacific Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 264. China Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 265. China Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 266. China Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 267. Japan Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 268. Japan Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 269. Japan Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 270. India Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 271. India Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 272. India Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 273. South Korea Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 274. South Korea Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 275. South Korea Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 276. Taiwan Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 277. Taiwan Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 278. Taiwan Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 279. Australia Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 280. Australia Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 281. Australia Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 282. Rest of Asia-Pacific Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 283. Rest of Asia-Pacific Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 284. Rest of Asia-Pacific Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 285. Europe Over The Counter (OTC) Drugs, by Country USD Million (2019-2024)
  • Table 286. Europe Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 287. Europe Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 288. Europe Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 289. Germany Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 290. Germany Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 291. Germany Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 292. France Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 293. France Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 294. France Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 295. Italy Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 296. Italy Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 297. Italy Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 298. United Kingdom Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 299. United Kingdom Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 300. United Kingdom Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 301. Netherlands Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 302. Netherlands Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 303. Netherlands Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 304. Rest of Europe Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 305. Rest of Europe Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 306. Rest of Europe Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 307. MEA Over The Counter (OTC) Drugs, by Country USD Million (2019-2024)
  • Table 308. MEA Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 309. MEA Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 310. MEA Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 311. Middle East Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 312. Middle East Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 313. Middle East Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 314. Africa Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 315. Africa Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 316. Africa Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 317. North America Over The Counter (OTC) Drugs, by Country USD Million (2019-2024)
  • Table 318. North America Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 319. North America Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 320. North America Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 321. United States Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 322. United States Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 323. United States Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 324. Canada Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 325. Canada Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 326. Canada Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 327. Mexico Over The Counter (OTC) Drugs, by Type USD Million (2019-2024)
  • Table 328. Mexico Over The Counter (OTC) Drugs, by Distribution Chanel USD Million (2019-2024)
  • Table 329. Mexico Over The Counter (OTC) Drugs, by Form USD Million (2019-2024)
  • Table 330. Over The Counter (OTC) Drugs Sales: by Type(K Units)
  • Table 331. Over The Counter (OTC) Drugs Sales Analgesics , by Region K Units (2019-2024)
  • Table 332. Over The Counter (OTC) Drugs Sales Dermatology Products , by Region K Units (2019-2024)
  • Table 333. Over The Counter (OTC) Drugs Sales Gastrointestinal Products , by Region K Units (2019-2024)
  • Table 334. Over The Counter (OTC) Drugs Sales Vitamins, Mineral, and Supplements (VMS) , by Region K Units (2019-2024)
  • Table 335. Over The Counter (OTC) Drugs Sales Weight Loss/Dietary Products , by Region K Units (2019-2024)
  • Table 336. Over The Counter (OTC) Drugs Sales Ophthalmic Products , by Region K Units (2019-2024)
  • Table 337. Over The Counter (OTC) Drugs Sales Sleeping Aids , by Region K Units (2019-2024)
  • Table 338. Over The Counter (OTC) Drugs Sales Others , by Region K Units (2019-2024)
  • Table 339. Over The Counter (OTC) Drugs Sales: by Distribution Chanel(K Units)
  • Table 340. Over The Counter (OTC) Drugs Sales Pharmacies , by Region K Units (2019-2024)
  • Table 341. Over The Counter (OTC) Drugs Sales Grocery Stores , by Region K Units (2019-2024)
  • Table 342. Over The Counter (OTC) Drugs Sales Vitamin and Health Food Stores , by Region K Units (2019-2024)
  • Table 343. Over The Counter (OTC) Drugs Sales Online Pharmacy , by Region K Units (2019-2024)
  • Table 344. Over The Counter (OTC) Drugs Sales Others , by Region K Units (2019-2024)
  • Table 345. Over The Counter (OTC) Drugs Sales: by Form(K Units)
  • Table 346. Over The Counter (OTC) Drugs Sales Tablets , by Region K Units (2019-2024)
  • Table 347. Over The Counter (OTC) Drugs Sales Hard Capsules , by Region K Units (2019-2024)
  • Table 348. Over The Counter (OTC) Drugs Sales Powders , by Region K Units (2019-2024)
  • Table 349. Over The Counter (OTC) Drugs Sales Ointments , by Region K Units (2019-2024)
  • Table 350. Over The Counter (OTC) Drugs Sales Soft Capsules , by Region K Units (2019-2024)
  • Table 351. Over The Counter (OTC) Drugs Sales Liquids , by Region K Units (2019-2024)
  • Table 352. Over The Counter (OTC) Drugs Sales Others , by Region K Units (2019-2024)
  • Table 353. South America Over The Counter (OTC) Drugs Sales, by Country K Units (2019-2024)
  • Table 354. South America Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 355. South America Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 356. South America Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 357. Brazil Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 358. Brazil Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 359. Brazil Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 360. Argentina Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 361. Argentina Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 362. Argentina Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 363. Rest of South America Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 364. Rest of South America Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 365. Rest of South America Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 366. Asia Pacific Over The Counter (OTC) Drugs Sales, by Country K Units (2019-2024)
  • Table 367. Asia Pacific Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 368. Asia Pacific Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 369. Asia Pacific Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 370. China Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 371. China Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 372. China Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 373. Japan Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 374. Japan Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 375. Japan Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 376. India Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 377. India Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 378. India Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 379. South Korea Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 380. South Korea Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 381. South Korea Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 382. Taiwan Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 383. Taiwan Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 384. Taiwan Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 385. Australia Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 386. Australia Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 387. Australia Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 388. Rest of Asia-Pacific Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 389. Rest of Asia-Pacific Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 390. Rest of Asia-Pacific Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 391. Europe Over The Counter (OTC) Drugs Sales, by Country K Units (2019-2024)
  • Table 392. Europe Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 393. Europe Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 394. Europe Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 395. Germany Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 396. Germany Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 397. Germany Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 398. France Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 399. France Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 400. France Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 401. Italy Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 402. Italy Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 403. Italy Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 404. United Kingdom Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 405. United Kingdom Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 406. United Kingdom Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 407. Netherlands Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 408. Netherlands Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 409. Netherlands Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 410. Rest of Europe Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 411. Rest of Europe Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 412. Rest of Europe Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 413. MEA Over The Counter (OTC) Drugs Sales, by Country K Units (2019-2024)
  • Table 414. MEA Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 415. MEA Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 416. MEA Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 417. Middle East Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 418. Middle East Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 419. Middle East Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 420. Africa Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 421. Africa Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 422. Africa Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 423. North America Over The Counter (OTC) Drugs Sales, by Country K Units (2019-2024)
  • Table 424. North America Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 425. North America Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 426. North America Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 427. United States Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 428. United States Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 429. United States Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 430. Canada Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 431. Canada Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 432. Canada Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 433. Mexico Over The Counter (OTC) Drugs Sales, by Type K Units (2019-2024)
  • Table 434. Mexico Over The Counter (OTC) Drugs Sales, by Distribution Chanel K Units (2019-2024)
  • Table 435. Mexico Over The Counter (OTC) Drugs Sales, by Form K Units (2019-2024)
  • Table 436. Over The Counter (OTC) Drugs: by Type(USD/Units)
  • Table 437. Research Programs/Design for This Report
  • Table 438. Key Data Information from Secondary Sources
  • Table 439. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Over The Counter (OTC) Drugs: by Type USD Million (2013-2018)
  • Figure 5. Global Over The Counter (OTC) Drugs: by Distribution Chanel USD Million (2013-2018)
  • Figure 6. Global Over The Counter (OTC) Drugs: by Form USD Million (2013-2018)
  • Figure 7. South America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 8. Asia Pacific Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 9. Europe Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 10. MEA Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 11. North America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 12. Global Over The Counter (OTC) Drugs: by Type K Units (2013-2018)
  • Figure 13. Global Over The Counter (OTC) Drugs: by Distribution Chanel K Units (2013-2018)
  • Figure 14. Global Over The Counter (OTC) Drugs: by Form K Units (2013-2018)
  • Figure 15. South America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 16. Asia Pacific Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 17. Europe Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 18. MEA Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 19. North America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 20. Global Over The Counter (OTC) Drugs: by Type USD/Units (2013-2018)
  • Figure 21. Global Over The Counter (OTC) Drugs share by Players 2018 (%)
  • Figure 22. Global Over The Counter (OTC) Drugs share by Players (Top 3) 2018(%)
  • Figure 23. Global Over The Counter (OTC) Drugs share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer Inc. (United States) Revenue: by Geography 2018
  • Figure 27. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis International AG (Switzerland) Revenue: by Geography 2018
  • Figure 29. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Roche Holding AG (Switzerland) Revenue: by Geography 2018
  • Figure 31. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck & Co., Inc. (United States) Revenue: by Geography 2018
  • Figure 33. Sanofi S.A (France) Revenue, Net Income and Gross profit
  • Figure 34. Sanofi S.A (France) Revenue: by Geography 2018
  • Figure 35. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 36. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 37. Gilead Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Gilead Sciences, Inc. (United States) Revenue: by Geography 2018
  • Figure 39. GlaxoSmithKline plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. GlaxoSmithKline plc. (United Kingdom) Revenue: by Geography 2018
  • Figure 41. Bayer Healthcare AG (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Bayer Healthcare AG (Germany) Revenue: by Geography 2018
  • Figure 43. AstraZeneca plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 44. AstraZeneca plc. (United Kingdom) Revenue: by Geography 2018
  • Figure 45. Global Over The Counter (OTC) Drugs: by Type USD Million (2019-2024)
  • Figure 46. Global Over The Counter (OTC) Drugs: by Distribution Chanel USD Million (2019-2024)
  • Figure 47. Global Over The Counter (OTC) Drugs: by Form USD Million (2019-2024)
  • Figure 48. South America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 49. Asia Pacific Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 50. Europe Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 51. MEA Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 52. North America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 53. Global Over The Counter (OTC) Drugs: by Type K Units (2019-2024)
  • Figure 54. Global Over The Counter (OTC) Drugs: by Distribution Chanel K Units (2019-2024)
  • Figure 55. Global Over The Counter (OTC) Drugs: by Form K Units (2019-2024)
  • Figure 56. South America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 57. Asia Pacific Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 58. Europe Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 59. MEA Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 60. North America Over The Counter (OTC) Drugs Share (%), by Country
  • Figure 61. Global Over The Counter (OTC) Drugs: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Pfizer Inc. (United States)
  • Novartis International AG (Switzerland)
  • Roche Holding AG (Switzerland)
  • Merck & Co., Inc. (United States)
  • Sanofi S.A (France)
  • Johnson & Johnson (United States)
  • Gilead Sciences, Inc. (United States)
  • GlaxoSmithKline plc. (United Kingdom)
  • Bayer Healthcare AG (Germany)
  • AstraZeneca plc. (United Kingdom)
Select User Access Type

Key Highlights of Report


Nov 2019 241 Pages 57 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Over The Counter (OTC) Drugs Quantitative research analysis
Global (United States, European Union and China) Over The Counter (OTC) Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global (United States, European Union and China) Over The Counter (OTC) Drugs Report?

Have a Query? Click Here

Other Related Reports

Intravenous (IV) Ibuprofen Comprehensive Study by Application (Pediatrics, Adults), Indication (Pain/Inflammatory, Fever), Form (Tablet, Capsule, Suspension, Other) Players and Region - Global Market...
$ 3500
Anticholinergic Drugs Comprehensive Study by Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), Application (Overactive Bladder, Parkinson’s Disease, Chronic Obstructive Pulmonary Disease...
$ 3650
Candesartan Comprehensive Study by Application (Hypertension, Cardiovascular Risks, Chronic Kidney Diseases), Doses (4 mg, 8 mg, 16 mg, 32 mg), Distribution Channel (Hospital Pharmacies, Retail Pharm...
$ 3450
Antifibrinolytic Drugs Comprehensive Study by Drug Type (Amicar, Aminocaproic acid, Aprotinin, Cyklokapron, Fibrinogen, human, Lysteda, RiaSTAP, Tranexamic acid injection, Tranexamic acid oral, Trasy...
$ 3750
Botulism Illness Comprehensive Study by Type (Antibiotics, Antitoxins, Other), Application (Hospitals, Clinics, Other), Distribution Channel (OTC, Prescribed) Players and Region - Global Market Outlo...
$ 3500
Drug Eluting Beads Comprehensive Study by Type (LC Beads, QuadraSpheres, Oncozene Beads), Application (Hospitals, Specialized Clinics, Ambulatory Surgical Centers, Research Centers), Drug (Doxorubici...
$ 3800